Radius Health Quick Ratio 2010-2020 | RDUS

Historical quick ratio values for Radius Health (RDUS) over the last 10 years.
Radius Health Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-03-31 $0.18B $0.06B 2.95
2019-12-31 $0.20B $0.06B 3.23
2019-09-30 $0.21B $0.06B 3.71
2019-06-30 $0.22B $0.05B 4.28
2019-03-31 $0.24B $0.05B 5.04
2018-12-31 $0.27B $0.05B 5.79
2018-09-30 $0.26B $0.05B 5.39
2018-06-30 $0.25B $0.05B 5.25
2018-03-31 $0.25B $0.04B 6.41
2017-12-31 $0.27B $0.05B 4.96
2017-09-30 $0.49B $0.04B 12.79
2017-06-30 $0.22B $0.03B 6.98
2017-03-31 $0.00B $0.03B 0.00
2016-12-31 $0.00B $0.03B 0.00
2016-09-30 $0.00B $0.03B 0.00
2016-06-30 $0.00B $0.02B 0.00
2016-03-31 $0.00B $0.02B 0.00
2015-12-31 $0.00B $0.02B 0.00
2015-09-30 $0.00B $0.02B 0.00
2015-06-30 $0.00B $0.02B 0.00
2015-03-31 $0.00B $0.02B 0.00
2014-12-31 $0.00B $0.02B 0.00
2014-09-30 $0.00B $0.03B 0.00
2014-06-30 $0.00B $0.02B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2012-12-31 $0.00B $0.02B 0.00
2011-12-31 $0.00B $0.01B 0.00
2010-12-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.583B $0.173B
Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.195B 38.13
Takeda Pharmaceutical (TAK) Japan $60.564B 10.61
Astellas Pharma (ALPMY) Japan $33.885B 16.92
Eisai (ESALY) Japan $23.619B 44.00
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $14.734B 19.32
Grifols, S.A (GRFS) Spain $13.834B 17.20
Catalent (CTLT) United States $12.084B 46.71
Neurocrine Biosciences (NBIX) United States $11.457B 52.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $8.035B 42.72
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.623B 0.00
Orion OYJ (ORINY) Finland $7.297B 32.70
IPSEN SA ADR (IPSEY) France $6.744B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.522B 10.44
United Therapeutics (UTHR) United States $5.416B 10.26
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.147B 12.62
Evotec AG (EVTCY) Germany $4.076B 65.73
Nektar Therapeutics (NKTR) United States $3.880B 0.00
ChemoCentryx (CCXI) United States $3.832B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.335B 364.11
PTC Therapeutics (PTCT) United States $3.204B 0.00
FibroGen (FGEN) United States $3.022B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.629B 10.81
Cronos Group (CRON) Canada $2.243B 64.30
Pacira BioSciences (PCRX) United States $1.836B 37.57
Sage Therapeutics (SAGE) United States $1.807B 0.00
Xencor (XNCR) United States $1.767B 0.00
USANA Health Sciences (USNA) United States $1.762B 18.07
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.737B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.674B 0.00
Heron Therapeutics (HRTX) United States $1.673B 0.00
Zogenix (ZGNX) United States $1.669B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.667B 12.76
Corcept Therapeutics (CORT) United States $1.641B 16.27
Akebia Therapeutics (AKBA) United States $1.473B 0.00
Portola Pharmaceuticals (PTLA) United States $1.409B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.407B 15.16
Karyopharm Therapeutics (KPTI) United States $1.322B 0.00
Tilray (TLRY) Canada $1.249B 0.00
Translate Bio (TBIO) United States $1.249B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.177B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.008B 45.01
Indivior (INVVY) United States $0.916B 11.36
ImmunoGen (IMGN) United States $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.834B 0.00
Endo (ENDP) Ireland $0.829B 1.28
Molecular Templates (MTEM) United States $0.726B 0.00
Aerie Pharmaceuticals (AERI) United States $0.704B 0.00
Collegium Pharmaceutical (COLL) United States $0.696B 0.00
Ardelyx (ARDX) United States $0.651B 0.00
Trillium Therapeutics (TRIL) Canada $0.641B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.519B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.511B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
DURECT (DRRX) United States $0.478B 0.00
Siga Technologies (SIGA) United States $0.477B 0.00
Flexion Therapeutics (FLXN) United States $0.470B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.465B 11.25
Harpoon Therapeutics (HARP) United States $0.457B 0.00
Organogenesis Holdings (ORGO) United States $0.444B 0.00
MEI Pharma (MEIP) United States $0.440B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 16.73
Calithera Biosciences (CALA) United States $0.402B 0.00
Ocular Therapeutix (OCUL) United States $0.377B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.332B 0.00
TherapeuticsMD (TXMD) United States $0.310B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Lannett Co Inc (LCI) United States $0.302B 6.63
Concert Pharmaceuticals (CNCE) United States $0.294B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.279B 0.00
Redhill Biopharma (RDHL) Israel $0.252B 0.00
Rafael Holdings (RFL) United States $0.242B 0.00
OptiNose (OPTN) United States $0.227B 0.00
VAXART, INC (VXRT) United States $0.217B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
PROFOUND MEDICL (PROF) Canada $0.193B 0.00
Jounce Therapeutics (JNCE) United States $0.188B 4.49
Taiwan Liposome (TLC) Taiwan $0.187B 0.00
IMV INC (IMV) Canada $0.186B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 24.00
Xeris Pharmaceuticals (XERS) United States $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.178B 0.00
Altimmune (ALT) United States $0.139B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.120B 0.00
Champions Oncology (CSBR) United States $0.115B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.112B 0.00
Recro Pharma (REPH) United States $0.109B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.104B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Sundial Growers (SNDL) Canada $0.089B 0.00
Otonomy (OTIC) United States $0.085B 0.00
Onconova Therapeutics (ONTX) United States $0.085B 0.00
CV Sciences (CVSI) United States $0.084B 0.00
CTI BioPharma (CTIC) United States $0.082B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.081B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.074B 0.00
Heat Biologics (HTBX) United States $0.068B 0.00
Biomerica (BMRA) United States $0.062B 0.00
Aclaris Therapeutics (ACRS) United States $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.055B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.00
GTx (ONCT) United States $0.050B 0.00
IsoRay (ISR) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.73
Natural Alternatives (NAII) United States $0.046B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
Lipocine (LPCN) United States $0.043B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
AgeX Therapeutics (AGE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 7.28
Neos Therapeutics (NEOS) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00